A cellular thermal shift assay for detecting amino acid sites involved in drug target engagement

Liyuan Peng1, Jingwen Jiang1, Li Zhou1

  • 1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital and West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu 610041, P.R. China.

STAR Protocols
|June 9, 2022
PubMed

Insights

This study introduces a cellular thermal shift assay to identify specific amino acid sites involved in drug-target interactions. This method helps assess drug engagement within cells, aiding drug development.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Understanding drug-target interactions at the cellular level is crucial for drug development and efficacy.
  • Identifying specific amino acid residues involved in binding enhances the precision of drug design.

Purpose of the Study:

  • To present a protocol for detecting amino acid sites engaged in drug-target interactions.
  • To provide a method for assessing drug-target engagement *in situ*.

Main Methods:

  • Utilizing a cellular thermal shift assay (CTSA) based on ligand-induced protein thermal stabilization.
  • Generating cell lines expressing wild-type or mutated target proteins.
  • Implementing drug treatment protocols.

Main Results:

  • The protocol successfully detects amino acid sites involved in drug-target engagement.
  • Demonstrates the utility of CTSA for *in situ* analysis of drug-target interactions.

Conclusions:

  • The described cellular thermal shift assay protocol offers a convenient method for assessing amino acid sites in drug-target interactions.
  • This approach facilitates a deeper understanding of molecular mechanisms underlying drug efficacy.

Related Concept Videos